F13.92
Sedative, hypnotic or anxiolytic use, unspecified with intoxication
Clinical Classification Guidelines
Excludes Type 1
- sedative, hypnotic or anxiolytic use, unspecified with withdrawal (F13.93-)
Medical Intelligence & Overview
ICD-10 Code F13.92 pertains to cases where an individual has used sedative, hypnotic, or anxiolytic medications and is experiencing intoxication as a result. These medications are often prescribed for conditions such as anxiety, sleep disorders, and insomnia. However, misuse or excessive consumption can lead to intoxication, which may pose serious health risks. This guide offers a patient-friendly overview of this condition to foster awareness and understanding.
Causes & Symptoms
Clinical Causes: Unintentional overdose of prescribed sedatives, hypnotics, or anxiolytics Intentional misuse or recreational use of these medications to achieve a desired effect Mixing sedative drugs with alcohol or other central nervous system depressants Lack of proper medical supervision or failure to follow prescribed dosages Development of dependence leading to increased use over time Underlying mental health conditions leading to increased medication use
Key Symptoms: Drowsiness or excessive sleepiness Confusion or disorientation Impaired coordination and motor skills Slurred speech Respiratory depression or slowed breathing Dizziness or lightheadedness Blurred vision Unusual behavior or agitation Loss of consciousness in severe cases Pulse rate changes or low blood pressure
Diagnostic & Treatment
Diagnosis Path: Healthcare providers diagnose intoxication through a combination of patient history, physical examination, and possibly laboratory tests. They will assess recent medication use, observe signs of intoxication, and evaluate other potential causes of symptoms. In some cases, blood or urine tests may be used to confirm the presence of sedative, hypnotic, or anxiolytic substances in the system.
Treatment Protocols: Treatment typically involves supportive care tailored to the severity of intoxication. This may include monitoring vital signs, ensuring airway stability, and providing sedation management. In severe instances, medical interventions such as administration of activated charcoal, flumazenil (a benzodiazepine antagonist), or hospitalization for close observation may be necessary. Long-term strategies focus on addressing substance misuse, adjusting medication regimens, and preventing future incidents through education and medical oversight.
Clinical Advice & FAQs
Billing Guidance
Is F13.92 a billable ICD-10 code?
Yes, F13.92 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.92?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic use, unspecified with intoxication and any associated comorbidities for accurate reporting.
Cite this Clinical Reference